Cargando…

Using a Bayesian approach with reverse philosophy to design clinical trials in rare diseases

Detalles Bibliográficos
Autores principales:	Billingham, Lucinda, Hall, Emma, Cruickshank, Clare, Barber, Jim, Nicholson, Steve
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980538/ http://dx.doi.org/10.1186/1745-6215-14-S1-O58

Ejemplares similares

Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia
por: Yap, Christina, et al.
Publicado: (2011)

Dose transition pathways: a design, analysis and operational tool for dose-finding trials using model-based designs
por: Yap, Christina, et al.
Publicado: (2015)

Implementation of adaptive dose-finding designs in two early phase haematological trials: clinical, operational, and methodological challenges
por: Yap, Christina, et al.
Publicado: (2013)

Evaluation of methods to adjust for treatment switching in clinical trials
por: Fox, Richard, et al.
Publicado: (2011)

Crossing survival curves: alternatives to the log-rank test
por: Bouliotis, George, et al.
Publicado: (2011)

Using meta-analysis of Phase II trials to predict Phase III trial results
por: Burke, Danielle, et al.
Publicado: (2013)

Stratified medicine in practice: review of predictive biomarkers in European Medicines Agency (EMA) indications
por: Malottki, Kinga, et al.
Publicado: (2011)

Trials in rare diseases: the need to think differently
por: Billingham, Lucinda, et al.
Publicado: (2011)

Trial-by-trial modeling of electrophysiological signals during inverse Bayesian inference
por: Kolossa, Antonio, et al.
Publicado: (2014)

Comparison of a frequentist and Bayesian response-adaptive randomisation approach in multi-stage phase II selection trials with multiple experimental arms
por: Yap, Christina, et al.
Publicado: (2015)

Loss of oestrogen receptor alpha in long-term antioestrogen-resistant cells: reversal by a c-src inhibitor
por: Bensmail, A, et al.
Publicado: (2008)

An integrated approach to the development of a Bayesian response-adaptive dose-finding study using sas and winbugs
por: Hansen, Christian Holm, et al.
Publicado: (2013)

The use of Bayesian design in two trials in rare cancers
por: Dutton, Peter, et al.
Publicado: (2015)

Comparing MCMC and INLA for disease mapping with Bayesian hierarchical models
por: De Smedt, Tom, et al.
Publicado: (2015)

Bayesian analysis of trial-based cost-effectiveness in the presence of missing data: effects of including covariates on efficiency of estimation in the ASTER trial
por: Sharples, Linda, et al.
Publicado: (2011)

A Bayesian dose-finding procedure applied to a seamless phase I/II trial in rheumatoid arthritis
por: Whitehead, Anne, et al.
Publicado: (2011)

24 month outcomes from the Australian National Hand Hygiene Intiative (NHHI)
por: Russo, P, et al.
Publicado: (2011)

Modelling clinical trial recruitment using poisson processes
por: Brock, Kristian, et al.
Publicado: (2015)

Challenges in the development of prognostic models utilising clinical trials data
por: Snell, Kym, et al.
Publicado: (2013)

The development of an online database and mobile web application for the collection and analysis of hand hygiene compliance data
por: Russo, PL, et al.
Publicado: (2011)

Implementation of the Australian national hand hygiene initiative
por: Stewardson, AJ, et al.
Publicado: (2015)

German approach of coding rare diseases with ICD-10-GM and Orpha numbers in routine settings
por: Weber, Stefanie, et al.
Publicado: (2014)

O080 The Associations Between Sleep Environment Factors and Sleep Health in Individuals Living with Neurological Conditions
por: Cruickshank, T, et al.
Publicado: (2023)

Development of a single, practical measure of surgical site infection (SSI) for patient self-report and observer completion: a novel method of questionnaire design
por: Macefield, Rhiannon, et al.
Publicado: (2015)

Which support from the French Foundation of rare disease towards clinical trial set up in rare diseases?
por: Ravagnan, Luigi
Publicado: (2015)

Designing the CORONIS trial. Why a non-regular fractional factorial design?
por: Hardy, Pollyanna, et al.
Publicado: (2013)

The use of early decision modelling and value of information analysis in an adaptive trial design: results from the OPTIMA preliminary study
por: Hall, Peter, et al.
Publicado: (2015)

Reverse transcriptases of retroviruses and retroelements: an evolutionary perspective
por: Arkhipova, Irina R
Publicado: (2009)

Efficient design of a phase III trial of competing tests for personalised cancer treatment in the absence of gold standard outcome data: challenges and potential solutions
por: Hall, Peter, et al.
Publicado: (2013)

Marginal models for meta-analysis of diagnostic accuracy studies in frequentist and Bayesian framework using rstan and CopulaREMADA
por: Nyaga, Victoria, et al.
Publicado: (2015)

An adaptive biomarker strategy clinical trial design
por: Wason, James, et al.
Publicado: (2013)

Designing, implementing and analysing a virtual trial
por: Scott, Lauren J, et al.
Publicado: (2015)

Progress in the development of Reversed Chloroquine molecules as antimalarial therapy
por: Burgess, Steven J, et al.
Publicado: (2010)

A cell-type-specific dynamic Bayesian network model for spontaneous and optogenetically evoked activity in the primary visual cortex
por: Mohebi, Ali, et al.
Publicado: (2011)

Designing trials of complex interventions for efficacy and mechanisms evaluation
por: Emsley, Richard A, et al.
Publicado: (2011)

Statistical design of mental health complex intervention trials
por: Landau, Sabine
Publicado: (2011)

Evaluating statistical characteristics of biomarker-guided trial designs
por: Antoniou, Miranta, et al.
Publicado: (2015)

Evidence synthesis in trial design: an example from the neurosciences
por: Egan, Kieren, et al.
Publicado: (2013)

Adaptive enrichment in biomarker-stratified clinical trial design
por: Parashar, Deepak, et al.
Publicado: (2013)

Using adaptive designs for decision making within the optima trial: optimal personalized treatment of early breast cancer using multi-parameter tests
por: Dunn, Janet, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8brceovtqm0qqitdt13s2ausm4